Wealth Enhancement Advisory Services LLC Has $541,000 Position in Varonis Systems, Inc. $VRNS

Wealth Enhancement Advisory Services LLC grew its position in Varonis Systems, Inc. (NASDAQ:VRNS) by 58.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,582 shares of the technology company’s stock after purchasing an additional 3,901 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Varonis Systems were worth $541,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Goldman Sachs Group Inc. grew its holdings in shares of Varonis Systems by 26.2% during the first quarter. Goldman Sachs Group Inc. now owns 4,084,830 shares of the technology company’s stock worth $165,231,000 after purchasing an additional 848,408 shares during the last quarter. RGM Capital LLC lifted its position in Varonis Systems by 45.5% during the 1st quarter. RGM Capital LLC now owns 2,706,531 shares of the technology company’s stock worth $109,479,000 after buying an additional 846,475 shares in the last quarter. Voya Investment Management LLC grew its holdings in Varonis Systems by 98.6% during the 1st quarter. Voya Investment Management LLC now owns 2,321,317 shares of the technology company’s stock worth $93,897,000 after acquiring an additional 1,152,687 shares during the last quarter. Stephens Investment Management Group LLC increased its position in Varonis Systems by 14.7% in the 1st quarter. Stephens Investment Management Group LLC now owns 1,604,558 shares of the technology company’s stock valued at $64,904,000 after acquiring an additional 205,781 shares in the last quarter. Finally, Penserra Capital Management LLC increased its position in Varonis Systems by 52.2% in the 1st quarter. Penserra Capital Management LLC now owns 1,542,071 shares of the technology company’s stock valued at $62,376,000 after acquiring an additional 529,182 shares in the last quarter. Institutional investors own 95.65% of the company’s stock.

Wall Street Analysts Forecast Growth

VRNS has been the topic of a number of research reports. Wells Fargo & Company upgraded shares of Varonis Systems from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $51.00 to $70.00 in a research report on Monday, August 11th. B. Riley started coverage on Varonis Systems in a report on Tuesday, August 26th. They set a “buy” rating and a $80.00 price objective on the stock. Wedbush reiterated an “outperform” rating and issued a $65.00 price objective on shares of Varonis Systems in a research report on Wednesday, September 3rd. Citigroup boosted their target price on Varonis Systems from $51.00 to $58.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Finally, JPMorgan Chase & Co. upped their price target on Varonis Systems from $61.00 to $70.00 and gave the company an “overweight” rating in a research note on Wednesday, September 24th. Fourteen analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Varonis Systems currently has an average rating of “Moderate Buy” and a consensus price target of $63.41.

Varonis Systems Price Performance

Shares of VRNS opened at $59.33 on Monday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 1.32. The company’s fifty day simple moving average is $57.23 and its 200 day simple moving average is $50.09. Varonis Systems, Inc. has a 1-year low of $36.53 and a 1-year high of $60.58. The company has a market cap of $6.65 billion, a price-to-earnings ratio of -64.49 and a beta of 0.64.

Varonis Systems (NASDAQ:VRNS) last announced its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. The company had revenue of $152.16 million during the quarter, compared to the consensus estimate of $147.80 million. Varonis Systems had a negative net margin of 17.30% and a negative return on equity of 23.06%. The company’s quarterly revenue was up 16.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.05 EPS. Varonis Systems has set its FY 2025 guidance at 0.160-0.180 EPS. Q3 2025 guidance at 0.070-0.080 EPS. On average, research analysts forecast that Varonis Systems, Inc. will post -0.83 earnings per share for the current fiscal year.

Insider Activity at Varonis Systems

In other news, Director Den Bosch Fred Van sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $55.08, for a total value of $165,240.00. Following the completion of the sale, the director directly owned 128,666 shares of the company’s stock, valued at $7,086,923.28. This trade represents a 2.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Guy Melamed sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $59.59, for a total value of $89,385.00. Following the transaction, the chief financial officer directly owned 412,105 shares in the company, valued at $24,557,336.95. The trade was a 0.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 113,386 shares of company stock worth $6,429,405 in the last 90 days. Corporate insiders own 2.30% of the company’s stock.

Varonis Systems Company Profile

Varonis Systems, Inc provides software products and services that allow enterprises to manage, analyze, alert, and secure enterprise data in North America, Europe, the Middle East, Africa, and internationally. Its software enables enterprises to protect data stored on premises and in the cloud, including sensitive files and emails; confidential personal data belonging to customers, and patients and employees' data; financial records; source code, strategic and product plans; and other intellectual property.